Nov 13 (Reuters) – GALDERMA GROUP AG: * MEXICO BECOMES FIRST MARKET WORLDWIDE TO RECEIVE APPROVAL FOR GALDERMA'S RESTYLANE® SHAYPE™ FOR BOTH CHIN AND ITS FIRST JAWLINE INDICATION * GRESTYLANE SHAYPE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
London (PA Media/dpa) - Adolescents turning into entirely different – and often far more unpleasant –…
By Sethuraman N R and Helen Clark NEW DELHI/PERTH, Nov 13 (Reuters) - Oil prices…
By Foo Yun Chee and Padraic Halpin DUBLIN, Nov 13 (Reuters) - European Union leaders…
Berlin (dpa) - As a starter for anyone who needs warming up with some winter…
Nov 13 (Reuters) - Hokuto Corp: * HOKUTO CORP - TO BUY UP TO 80,000…
Nov 13 (Reuters) - Russian lender Sovcombank said on Friday: * Net profit for the…